| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8794566 | Ophthalmology Retina | 2018 | 10 Pages |
Abstract
Sirolimus did not result in different rates of GA growth in this phase II study. Immunosuppression may be important for some stages of the AMD process, but may not necessarily be the main pathway for the development of GA.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Gary MS, Traci E. PhD, Amitha MD, PhD, Ronald P. MD, Barbara MD, Jack MD, Michael MD, John MD, G. Baker MD, Michael J. MD, Gary E. MD, JD, Alexander MD, Alan MD, Emily Y. MD,